Financial results - K-UBIK PHARMA INDUSTRIES S.R.L.

Financial Summary - K-Ubik Pharma Industries S.r.l.
Unique identification code: 37257470
Registration number: J40/3866/2017
Nace: 4646
Sales - Ron
135.602
Net Profit - Ron
33.919
Employees
1
Open Account
Company K-Ubik Pharma Industries S.r.l. with Fiscal Code 37257470 recorded a turnover of 2024 of 135.602, with a net profit of 33.919 and having an average number of employees of 1. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - K-Ubik Pharma Industries S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - 0 3.868 10.758 6.008 3.484 109.698 98.286 135.602
Total Income - EUR - - 0 3.868 10.758 6.008 3.545 109.733 98.360 135.676
Total Expenses - EUR - - 171 120 1.054 2.794 3.416 91.252 96.174 95.342
Gross Profit/Loss - EUR - - -171 3.748 9.704 3.214 129 18.481 2.186 40.335
Net Profit/Loss - EUR - - -171 3.632 9.381 3.040 35 15.519 1.659 33.919
Employees - - 0 0 0 0 0 0 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 38.7%, from 98.286 euro in the year 2023, to 135.602 euro in 2024. The Net Profit increased by 32.269 euro, from 1.659 euro in 2023, to 33.919 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - K-Ubik Pharma Industries S.r.l.

Rating financiar

Financial Rating -
K-UBIK PHARMA INDUSTRIES S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
K-Ubik Pharma Industries S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
K-Ubik Pharma Industries S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
K-Ubik Pharma Industries S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - K-Ubik Pharma Industries S.r.l. - CUI 37257470

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - 50 0 0 0 0 0 3.779 3.866
Current Assets - - 2.189 5.729 15.085 17.819 33.995 119.289 101.000 111.609
Inventories - - 0 0 0 0 16.209 22.826 25.522 23.023
Receivables - - 0 0 0 1.857 4.297 68.346 52.075 70.228
Cash - - 2.189 5.729 15.085 15.961 13.489 28.117 23.402 18.358
Shareholders Funds - - 2.018 5.613 14.885 17.643 17.287 32.859 34.419 63.120
Social Capital - - 2.189 2.149 2.107 2.067 2.022 2.028 2.022 2.010
Debts - - 222 116 200 176 17.210 86.750 70.620 52.834
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 111.609 euro in 2024 which includes Inventories of 23.023 euro, Receivables of 70.228 euro and cash availability of 18.358 euro.
The company's Equity was valued at 63.120 euro, while total Liabilities amounted to 52.834 euro. Equity increased by 28.894 euro, from 34.419 euro in 2023, to 63.120 in 2024.

Risk Reports Prices

Reviews - K-Ubik Pharma Industries S.r.l.

Comments - K-Ubik Pharma Industries S.r.l.

Comments can only be added from a RisCo client account. Login
See Comments

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.